CNX-19669-43845
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 327 / FL
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-20
Dose 1 — Pfizer-BioNTech
-
2020-12-21
Registered in v-safe
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: Pain, Redness · Fatigue or tirednessFree text: Warmth at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Upper-airway cough syndrome — Feeling: GoodFree text: Very small amount of post-nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2021-01-03
-
2021-01-10
Dose 2 — Pfizer-BioNTech
-
2021-01-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Headache, NauseaAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-16
- 2021-01-19
-
2021-01-24
Survey response — day 14, dose 2MedDRA: Headache, Nausea — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Nausea and headacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-04-11
- 2021-07-11
-
2021-09-10
Dose 3 — Pfizer-BioNTech
-
2021-09-11
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-13
- 2021-09-14
- 2021-09-15
- 2021-09-16
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-12-10
- 2022-03-12
- 2022-09-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-20 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech | |
| 3 | 2021-09-10 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Warmth at injection site
Systemic reaction (other): Very small amount of post-nasal drip
Release 2 — day 14, dose 2
Symptoms: Nausea and headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release